This hypothesis might be supported by the fact that the downregulation of TFAM expression has promoted ROS-dependent activation of JNK/p38 MAPK and apoptosis, as reported in non-small cell lung cancer [41]. The gene discussed is TFAM; the disease is non-small cell lung carcinoma.